AU2003224781A1 - Crystalline forms of rabeprazole sodium - Google Patents

Crystalline forms of rabeprazole sodium

Info

Publication number
AU2003224781A1
AU2003224781A1 AU2003224781A AU2003224781A AU2003224781A1 AU 2003224781 A1 AU2003224781 A1 AU 2003224781A1 AU 2003224781 A AU2003224781 A AU 2003224781A AU 2003224781 A AU2003224781 A AU 2003224781A AU 2003224781 A1 AU2003224781 A1 AU 2003224781A1
Authority
AU
Australia
Prior art keywords
crystalline forms
rabeprazole sodium
rabeprazole
sodium
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003224781A
Inventor
Vijaya Bhaskar Bolugoddu
Sajja Eswaraiah
Madhusudhan Reddy Ganta
Ramchandra Reddy Pingili
Manne Satyanarayana Reddy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Original Assignee
Dr Reddys Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd filed Critical Dr Reddys Laboratories Ltd
Publication of AU2003224781A1 publication Critical patent/AU2003224781A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
AU2003224781A 2002-03-26 2003-03-25 Crystalline forms of rabeprazole sodium Abandoned AU2003224781A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN207MA2002 2002-03-26
IN207/MAS/02 2002-03-26
PCT/US2003/009307 WO2003082858A1 (en) 2002-03-26 2003-03-25 Crystalline forms of rabeprazole sodium

Publications (1)

Publication Number Publication Date
AU2003224781A1 true AU2003224781A1 (en) 2003-10-13

Family

ID=33397666

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003224781A Abandoned AU2003224781A1 (en) 2002-03-26 2003-03-25 Crystalline forms of rabeprazole sodium

Country Status (5)

Country Link
US (1) US20050234103A1 (en)
EP (1) EP1487820A1 (en)
AU (1) AU2003224781A1 (en)
CA (1) CA2480358A1 (en)
WO (1) WO2003082858A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040180935A1 (en) * 2003-02-28 2004-09-16 Dr. Reddy's Laboratories Limited Dr. Reddy's Laboratories Inc. Crystalline form Z of rabeprazole sodium and process for preparation thereof
US7557217B2 (en) * 2004-06-30 2009-07-07 Eisai R&D Management Co., Ltd. Process for production of benzimidazole derivative salt precipitate
ITMI20042437A1 (en) * 2004-12-21 2005-03-21 Dipharma Spa CRYSTALLINE FORM OF RABEPRAZOLO SODICO
BRPI0609622A2 (en) * 2005-03-30 2010-04-20 Lupin Ltd improved process for the production of rabeprazole sodium
WO2008017020A2 (en) * 2006-08-03 2008-02-07 Dr. Reddy's Laboratories Limited Process for preparing proton pump inhibitors
ITMI20062449A1 (en) 2006-12-19 2008-06-20 Dipharma Spa CRYSTALLINE FORM OF RABEPRAZOLO SODICO
JP2010215507A (en) * 2007-06-11 2010-09-30 Ohara Yakuhin Kogyo Kk Crystal of 2-[[4-(3-methoxypropoxy)-3-methylpyridine-2-yl]methylsulfinyl]-1h-benzimidazole sodium salt, and method of producing the same
SI22806A (en) * 2008-06-23 2009-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto New crystalline forms of sodium rabeprazole
US8071781B2 (en) 2008-11-11 2011-12-06 Syn-Tech Chem. & Pharm. Co., Ltd. Process for preparing rabeprazole sodium
CN113336741B (en) * 2021-05-07 2022-06-24 湖南德虹制药有限公司 Rabeprazole sodium anhydride crystal form and preparation method thereof
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI90544C (en) * 1986-11-13 1994-02-25 Eisai Co Ltd Process for Preparation as Drug Useful 2-Pyridin-2-yl-methylthio- and sulfinyl-1H-benzimidazole derivatives
SE8804628D0 (en) * 1988-12-22 1988-12-22 Ab Haessle NEW COMPOUNDS
SE8804629D0 (en) * 1988-12-22 1988-12-22 Ab Haessle NEW THERAPEUTICALLY ACTIVE COMPOUNDS
JP2001039975A (en) * 1999-07-26 2001-02-13 Eisai Co Ltd Crystal of sulfoxide derivative and its production
DE60123800T2 (en) * 2000-08-04 2007-10-11 Takeda Pharmaceutical Co. Ltd. SALTS OF BENZIMIDAZOLE DERIVATIVES AND THEIR USE
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs

Also Published As

Publication number Publication date
EP1487820A1 (en) 2004-12-22
US20050234103A1 (en) 2005-10-20
CA2480358A1 (en) 2003-10-09
WO2003082858A1 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
AU2003202924A1 (en) Variation of neural-stimulation parameters
AU2003239644A1 (en) Crystallization of sugars
AU2003278406A1 (en) Amorphous form of esomeprazole salts
AU2003277596A1 (en) Method of deuterization
AU2003206803A1 (en) Production of alkenones
AU2002330453A1 (en) Crystals of hydroxynorephedrine derivative
AU2003268687A1 (en) Novel salt of 2-acylaminothiazole derivative
AU2003240668A1 (en) Attenuation of metapneumovirus
AU2003224781A1 (en) Crystalline forms of rabeprazole sodium
AU2003238671A1 (en) Novel crystalline forms of s-omeprazole magnesium
AU2003222659A1 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
AUPS096002A0 (en) Method of construction
AU2003237598A1 (en) Process for the preparation of highly pure rabeprazole sodium salt
AU2003229459A1 (en) Methods of using thiazolidinedithione derivatives
AU2003241150A1 (en) Novel polymorphs of pantoprazole sodium
AU2003298725A1 (en) Preparation of metallotexaphyrins
AU2003256006A1 (en) Improved process for preparation of risperidone
AU2002249639A1 (en) Pyranocoumarin derivatives
AU2003238669A1 (en) Novel crystalline forms of parecoxib sodium
AU2003232362A1 (en) 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors
AU2003243432A1 (en) Process of making phosphordiamidite compounds
AU2003284704A1 (en) Substituted 1h-pyridine-2-one derivatives
EP1486485A4 (en) Novel crystals of 5-hydroxycarbamimidoyl-2-hydroxybenzenesulfonamide derivative
AU2003235129A1 (en) Process for preparation of 2-aminoketones
AU2003285006A1 (en) Method of preparation of oligosaccharides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase